KILITCH DRUGS(I)
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Kilitch Drugs(I) along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.31₹ 8.8
As on Oct 31, 2025, 4:01 PM IST
Kilitch Drugs(I) Price Performance
Today's LowToday's High
₹386.20₹395.25
₹390.55
52 Weeks' Low52 Weeks' High
₹278.16₹490.00
₹390.55
Open Price
₹388.30
Prev. Close
₹381.75
Volume
583
Over the last 5 years, the share price of Kilitch Drugs(I) has gained 34.79% CAGR. Over the past year, the corresponding return has been 22.31%.
Kilitch Drugs(I)’s current P/E of 24.38x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Kilitch Drugs(I) Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Kilitch Drugs(I) | 5.55 | 12.99 | -13.21 | 3.00 | 22.31 | 30.57 | 34.79 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Kilitch Drugs(I) has gained 22.31% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Kilitch Drugs(I) has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Kilitch Drugs(I) Financials
Kilitch Drugs(I) Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 383.73 | 387.3 |
| 10 | 374.97 | 381.73 |
| 20 | 364.92 | 374.33 |
| 50 | 368.17 | 376.82 |
| 100 | 403.74 | 383.72 |
| 200 | 375.68 | 377 |
Kilitch Drugs(I) Share Holding Pattern
In the latest quarter, Kilitch Drugs(I) saw a drop in promoter holding to 63.77%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 36.22% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Kilitch Drugs(I) Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 14, 2025, 8:10 PM IST | Kilitch Drugs(I) - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 27, 2025, 6:10 AM IST | Kilitch Drugs(I) - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 26, 2025, 7:38 PM IST | Kilitch Drugs(I) - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Sep 06, 2025, 2:09 AM IST | Kilitch Drugs(I) - Letter To Shareholders - Annual Report For FY 2024-25 |
| Sep 02, 2025, 12:01 AM IST | Kilitch Drugs(I) - Book Closure Intimation |
About Kilitch Drugs(I)
Kilitch Drugs(I) Ltd. is a Public Limited Listed company incorporated on 12/05/1992 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1992PLC066718 and registration number is 066718. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 181.59 Cr. and Equity Capital is Rs. 16.08 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressC-301/2, M.I.D.C., New Mumbai Maharashtra 400705
- Contact
Management
- Mr. Mukund P MehtaManaging Director
- Mr. Bhavin Mukund MehtaWhole Time Director
- Mrs. Mira B MehtaWhole Time Director
- Mr. Hemang J EngineerIndependent Director
- Mr. Venkita Subramanian RajanIndependent Director
- Prof. Vasudev Krishna MurtiIndependent Director
- Mr. Dipen J JainIndependent Director
FAQs on Kilitch Drugs(I) Share Price
What is the share price of Kilitch Drugs(I)?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Kilitch Drugs(I) is ₹390.55 as on Oct 31, 2025.
What kind of stock is Kilitch Drugs(I)?
The Kilitch Drugs(I) is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Kilitch Drugs(I)?
The market cap of Kilitch Drugs(I) is ₹682.71 Cr as on Oct 31, 2025.
What are today's High and Low prices of Kilitch Drugs(I)?
Today’s highest and lowest price of Kilitch Drugs(I) are ₹395.25 and ₹386.20.
What are the 52 Week High and 52 Week Low of Kilitch Drugs(I)?
The 52-week high/low is the highest and lowest price at which Kilitch Drugs(I) stock has traded in the past 52-week or nearly a year. The 52-week high of Kilitch Drugs(I) is ₹490.00 and 52-week low of Kilitch Drugs(I) is ₹278.16 as on Oct 31, 2025.
How has the Kilitch Drugs(I) performed historically in terms of returns?
The Kilitch Drugs(I) has shown returns of 2.31% over the past day, 12.99% for the past month, -13.21% over 3 months, 22.31% over 1 year, 30.57% across 3 years, and 34.79% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Kilitch Drugs(I)?
P/E ratio of and PB ratio of Kilitch Drugs(I) are 24.38 and 2.71 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse